Sign in

CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411458152
Phone
206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
Open-market buys, last 90 days
$72,488
in 2 filings
Open-market sales, last 90 days
$1,622,534
in 5 filings

Net −$1,550,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-12 Puhlmann Markus Chief Medical Officer Purchase +35,000 $0.84 $30K 178,542
2026-11-11 Puhlmann Markus Chief Medical Officer Purchase +6,000 $0.83 $5K 143,542
2026-03-02 Puhlmann Markus Chief Medical Officer Grant or award · Stock option (right to buy) +150,000 150,000
2025-03-03 Puhlmann Markus Chief Medical Officer Grant or award · Stock option (right to buy) +165,000 165,000
2024-06-20 Puhlmann Markus Chief Medical Officer Grant or award · Stock option (right to buy) +150,000 150,000
2024-01-24 Puhlmann Markus Chief Medical Officer Purchase +280,000 $0.50 $140K 1,375,425
2023-12-19 Puhlmann Markus Chief Medical Officer Purchase +400,000 $0.34 $137K 1,095,425
2023-12-18 Puhlmann Markus Chief Medical Officer Purchase +60,419 $0.26 $15K 695,425
2023-12-15 Puhlmann Markus Chief Medical Officer Purchase +135,006 $0.27 $36K 635,006
2023-12-12 Puhlmann Markus Chief Medical Officer Grant or award · Stock Options (right to buy) +1,477,619 2,885,688

Page 1 of 1 · 10 trades